Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.

Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Seldin DS, Sam F
Circ Heart Fail. 2008 1 (4): 249-57

PMID: 19808299 · PMCID: PMC2774449 · DOI:10.1161/CIRCHEARTFAILURE.108.788687

MeSH Terms (24)

Aged Amyloid Amyloidosis Biomarkers Cardiomyopathies Echocardiography Extracellular Matrix Female Heart Ventricles Humans Immunoglobulin Light Chains Kidney Diseases Male Matrix Metalloproteinase 9 Matrix Metalloproteinases Mutation Myocardium Natriuretic Peptide, Brain Peptide Hydrolases Prealbumin Tissue Inhibitor of Metalloproteinase-1 Tissue Inhibitor of Metalloproteinases Ventricular Function, Left Ventricular Remodeling

Connections (1)

This publication is referenced by other Labnodes entities: